Detalhe da pesquisa
1.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(18): 1672-1684, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870974
2.
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
N Engl J Med
; 386(21): 1973-1985, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403841
3.
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816.
Cancer Sci
; 115(2): 540-554, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38098261
4.
Changes in survival of patients with non-small cell lung cancer in Japan: An interrupted time series study.
Cancer Sci
; 114(3): 1154-1164, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369880
5.
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib.
Cancer Sci
; 114(2): 606-618, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169649
6.
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Lancet
; 399(10335): 1607-1617, 2022 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461558
7.
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer.
Future Oncol
; 19(8): 549-557, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815433
8.
Utility of the Ba/F3 cell system for exploring on-target mechanisms of resistance to targeted therapies for lung cancer.
Cancer Sci
; 113(3): 815-827, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34997674
9.
Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405).
Int J Clin Oncol
; 27(9): 1404-1412, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723758
10.
[Current Status and Future Perspectives of Molecular Targeted Therapies for Lung Cancer].
Kyobu Geka
; 75(1): 53-66, 2022 Jan.
Artigo
em Japonês
| MEDLINE | ID: mdl-35249077
11.
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.
Oncologist
; 26(4): e588-e596, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33325566
12.
Adjuvant therapy of operable nonsmall cell lung cancer: an update.
Curr Opin Oncol
; 33(1): 47-54, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33186180
13.
Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB-IIIA non-small cell lung cancer (WJTOG0101).
Int J Clin Oncol
; 26(12): 2216-2223, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463869
14.
The prevalence and risk factors associated with preoperative deep venous thrombosis in lung cancer surgery.
Surg Today
; 51(9): 1480-1487, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611651
15.
Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women.
Genomics
; 112(2): 1223-1232, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306748
16.
Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer.
Expert Opin Emerg Drugs
; 25(3): 229-249, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615820
17.
Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancer.
Surg Today
; 50(11): 1427-1433, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409869
18.
Performance of Oncomine Fusion Transcript kit for formalin-fixed, paraffin-embedded lung cancer specimens.
Cancer Sci
; 110(6): 2044-2049, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972901
19.
Osimertinib for Japanese patients with T790M-positive advanced non-small-cell lung cancer: A pooled subgroup analysis.
Cancer Sci
; 110(9): 2884-2893, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31265163
20.
Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations.
Hum Mol Genet
; 26(2): 454-465, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28025329